MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
preferred stock in clyra...
$2,145K
Proceeds from sale of
common stock, net of...
$2,027K
Proceeds from biolargo
warrant exercise-Clyra...
$1,894K
Proceeds from clyra
medical note...
$1,261K
Proceeds from sale of
common stock, net of...
$445K
Proceeds from sale of
common stock, net of...
$425K
Proceeds (repayments)
from debt...
$24K
Repayment of note
receivable
$481K
Net cash provided by
financing activities
$8,221K
Net cash provided by
(used in) investing...
$435K
Canceled cashflow
$46K
Net change in cash
$335K
Canceled cashflow
$8,321K
Credit loss expense
$3,886K
Stock option
compensation expense
$2,965K
Common stock issued for
services
$648K
Accounts payable and
accrued...
$377K
Contract liabilities
$280K
Accounts payable and
accrued...
$266K
Interest expense related
to amortization of...
$196K
Operating lease
right-of-use assets...
$148K
Depreciation expense
$145K
Finance lease right
-of-use asset...
$113K
Deposits
$99K
Inventories
-$20K
Loss on investment in
south korean joint...
-$14K
Equipment purchases
$46K
Net cash used in
operating activities
-$8,297K
Net effect of
foreign currency...
-$24K
Canceled cashflow
$9,157K
Net income (loss),
including portion...
-$15,189K
Accounts receivable
$1,814K
Prepaid expenses and
other assets
$226K
Operating lease
liabilities, net
-$137K
Finance lease
liability, net
$88K
Back
Back
Cash Flow
source: myfinsight.com
BLGO
BLGO